Detalhe da pesquisa
1.
Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.
Endocr J
; 69(4): 327-359, 2022 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35418526
2.
Increased Dosage of MRA Improves BP and Urinary Albumin Excretion in Primary Aldosteronism With Suppressed Plasma Renin.
J Endocr Soc
; 6(1): bvab174, 2022 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34909517
3.
γENaC/CD9 in urinary extracellular vesicles as a potential biomarker of MR activity.
J Endocrinol
; 252(2): 81-90, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34755678
4.
Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism.
J Endocr Soc
; 4(4): bvaa011, 2020 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32190802
5.
Diabetes Mellitus Itself Increases Cardio-Cerebrovascular Risk and Renal Complications in Primary Aldosteronism.
J Clin Endocrinol Metab
; 105(7)2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32275055
6.
The number of positive confirmatory tests is associated with the clinical presentation and incidence of cardiovascular and cerebrovascular events in primary aldosteronism.
Hypertens Res
; 42(8): 1186-1191, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30850754
7.
Clinical Characteristics of Acromegalic Patients With Paradoxical GH Response to Oral Glucose Load.
J Clin Endocrinol Metab
; 104(5): 1637-1644, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30476255